API

As a novel potassium-competitive acid blocker, VONOZOPRAN FUMARATE may provide reversible acid suppression by preventing K+ from binding to gastric H+/K+-ATPase. It has been clinically used for the short-term treatment of gastroesophageal reflux disease (GERD), peptic ulcer disease and Helicobacter pylori (H. pylori) infection.

Products still subject to third-party patent protection might be available solely for R&D purposes.

MOSAPRIDE CITRATE is a gastroprokinetic agent that acts as a selective 5HT4 agonist. The major active metabolite of mosapride, known as M1, additionally acts as a 5HT3 antagonist, which accelerates gastric emptying throughout the whole of the gastrointestinal tract in humans.

Products still subject to third-party patent protection might be available solely for R&D purposes.

Bilastine is a white to off-white crystalline powder that is sparingly soluble in methylene chloride and practically insoluble in acetone. It has an assay range of 98.0% to 102.0%.

Products still subject to third-party patent protection might be available solely for R&D purposes.

SORBITOL 70% TS02 is a clear, colourless, syrup liquid and it is miscible with water. It can be used as a moisturizer or sweetener in food, personal care, and health care. It is also an important raw material for industry.